Evidence that a biomarker is indeed significantly associated with a defined tumor type may be substantiated by level-1 or level-2 evidence. Level-1 evidence is usually obtained from high-powered ...

For multiplex immunofluorescence, the expression of CD206 in mice tumor tissues was detected with a monoclonal ... Meanwhile, the results of WB, flow cytometry, immunohistochemistry, and Perls blue ...

Abstract: Immunohistochemistry (IHC) examination is essential to determine the tumour subtypes, provide key prognostic factors, and develop personalized treatment plans for breast cancer. However, ...

Hypoxia is a common feature of solid tumors that has previously been linked to resistance to radiotherapy and chemotherapy, and more recently to immunotherapy. In particular, hypoxic tumors exclude T ...

1Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada. *Corresponding Author: Anne Monette, Lady Davis Institute for Medical Research, Jewish General Hospital, ...

Department of Chemical Engineering, University of Mississippi, University, Oxford, Mississippi 38677, United States Department of Biomedical Engineering, University of Mississippi, University, Oxford, ...

A device called a cyclotron sends tiny, high-energy beams of protons to the tumor. With proton therapy, the beams do not go past the tumor. It can cause fewer side effects because healthy tissue near ...

Or it might do the reverse. Depending on the gene involved, this might contribute to the process of oncogenesis. Through this complex process, the cancer tissue is prone to invade nearby tissue, ...